Galmed Pharmaceuticals
GLMD
#11038
Rank
โ‚ฌ4.5 M
Marketcap
4,22ย โ‚ฌ
Share price
21.05%
Change (1 day)
417.91%
Change (1 year)

Earnings for Galmed Pharmaceuticals (GLMD)

Earnings in 2026 (TTM): -โ‚ฌ9.75 Million

According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ9.4 Million a decrease over its 2024 earnings that were of -โ‚ฌ6.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galmed Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ9.75 Million3.74%
2025 -โ‚ฌ9.4 Million37.14%
2024 -โ‚ฌ6.86 Million8.75%
2023 -โ‚ฌ6.31 Million-61.31%
2022 -โ‚ฌ16.29 Million-44.97%
2021 -โ‚ฌ29.6 Million12.85%
2020 -โ‚ฌ26.23 Million40.61%
2019 -โ‚ฌ18.66 Million109.19%
2018 -โ‚ฌ8.92 Million-20.47%
2017 -โ‚ฌ11.22 Million-27%
2016 -โ‚ฌ15.36 Million58.6%
2015 -โ‚ฌ9.69 Million16.7%
2014 -โ‚ฌ8.3 Million-47.94%
2013 -โ‚ฌ15.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Evoke Pharma
EVOK
-โ‚ฌ4.31 Million-58.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-โ‚ฌ2.19 Billion 20,987.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚ฌ21.19 Million 104.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-โ‚ฌ82.96 Million 702.26%๐Ÿ‡บ๐Ÿ‡ธ USA